Skip to main content
. 2017 May 22;8(37):61264–61281. doi: 10.18632/oncotarget.18057

Figure 6. The differentiated metabolic pathways between subcutaneous and orthotopic xenograft groups based on the dominant metabolites in tissue metabonomes.

Figure 6

The pair-comparisons: (A), subcutaneous and orthotopic xenograft groups induced by Panc-1 cell; (B), subcutaneous and orthotopic xenograft groups induced by BxPC-3 cell. Abbreviations for the metabolites are listed in Table 1.